Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy in bronchial asthma.

E Alvarez-Cuesta1, E Gonzélez-Mancebo

  • 1Hospital Ramón y Cajal, Madrid, Spain.

Current Opinion in Pulmonary Medicine
|December 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does Rapid Drug Desensitization to Chemotherapy Affect Survival Outcomes?

Journal of investigational allergology & clinical immunology·2019
Same author

Chemotherapy in Mastocytosis: Administration Issues, Hypersensitivity, and Rapid Drug Desensitization.

Journal of investigational allergology & clinical immunology·2017
Same author

Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization.

Allergy·2015
Same author

Rapid desensitization to chemotherapy and monoclonal antibodies is effective and safe. Reply.

Allergy·2014
Same author

Desensitizing oxaliplatin-induced fever: a case report.

Journal of investigational allergology & clinical immunology·2014
Same author

Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.

Allergy·2013
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Allergen immunotherapy is a safe and effective treatment for allergic rhinitis and asthma. This therapy offers long-term benefits, potentially preventing disease progression and reducing overall healthcare costs.

Area of Science:

  • Immunology
  • Allergology
  • Respiratory Medicine

Background:

  • Increasing incidence and prevalence of allergic diseases globally.
  • Current treatments limited to allergen avoidance and immunotherapy.
  • Need for effective, long-term management strategies for allergic conditions.

Purpose of the Study:

  • To evaluate the efficacy and safety of allergen immunotherapy.
  • To explore the long-term benefits and cost-effectiveness of immunotherapy.
  • To assess immunotherapy's potential to alter the natural course of respiratory allergic diseases.

Main Methods:

  • Review of scientific data on allergen immunotherapy.
  • Analysis of patient outcomes in allergic rhinitis and asthma.
  • Assessment of long-term remission and disease progression data.

Related Experiment Videos

Main Results:

  • Allergen immunotherapy is effective and safe for selected patients with allergic rhinitis and asthma.
  • Immunotherapy leads to reduced long-term treatment costs.
  • Immunotherapy induces prolonged clinical remissions and may prevent asthma development in rhinitis patients.

Conclusions:

  • Allergen immunotherapy is a valuable etiological treatment for allergic diseases.
  • It offers sustained benefits, including potential disease modification.
  • Immunotherapy represents a crucial intervention for managing respiratory allergies and preventing disease progression.